Publication | Open Access

Phase II multicenter randomized study of amifostine for prevention of acute radiation rectal toxicity: Topical intrarectal versus subcutaneous application

OncologyEngineeringRadiation TherapyMedicineRadiation EffectRadiation ExposureToxicologyPharmacotherapyPhase Ii MulticenterRadiation EffectsPharmacologyRadiation OncologyNuclear Medicine